ADAPT 2-Hour Accelerated Diagnostic Protocol Calculator – Emergency Chest Pain
ADAPT clinical assessment
Complete the TIMI variables, ECG assessment, and paired 0- and 2-hour troponin I results.
Complete all required fields
About the ADAPT protocol
The ADAPT (2-hour accelerated diagnostic protocol) was evaluated in emergency-department patients presenting with chest pain suggestive of acute coronary syndrome. Its original low-risk classification requires all of the following: TIMI risk score of 0, no new ischemic changes on the initial ECG, and cardiac troponin I below the institutional cutoff at both 0 and 2 hours.
TIMI score variables
| Variable | Definition | Points |
|---|---|---|
| Age | ≥65 years | 1 |
| CAD risk factors | ≥3 risk factors (family history, hypertension, hypercholesterolemia, diabetes, current smoking) | 1 |
| Known CAD | Prior coronary stenosis ≥50% | 1 |
| Angina | ≥2 episodes in preceding 24 hours | 1 |
| Aspirin | Use in preceding 7 days | 1 |
| ECG | ST-segment deviation ≥0.5 mm | 1 |
| Biomarker | Elevated cardiac marker (here: cTnI at 0 h ≥ entered institutional cutoff) | 1 |
Original ADAPT performance
In the prospective ADAPT cohort (n=1,975), 392 patients (20%) were classified as low risk. One of those patients had a 30-day MACE: sensitivity 99.7% (95% CI 98.1–99.9) and negative predictive value 99.7% (95% CI 98.6–100.0). These are study-cohort estimates, not a guarantee of safety or an individualized probability.
Clinical use and limitations
- Designed as an adjunct for ED assessment of suspected ACS after immediate emergencies have been addressed.
- A TIMI score of 0 alone does not rule out ACS; all ADAPT components must be satisfied.
- Use the assay-specific institutional elevation cutoff and correct sampling interval. This tool is intentionally restricted to the original contemporary cTnI approach.
- Persistent/recurrent symptoms, dynamic ECG changes, clinical concern, or discordant results require further evaluation regardless of the calculator output.
- Low-risk classification is not an automatic discharge order. Disposition requires clinician assessment, follow-up arrangements, and local protocol.
Current guideline context
Contemporary guidance prefers high-sensitivity cardiac troponin and assay-specific accelerated pathways (e.g., validated 0/1-hour or 0/2-hour algorithms). The 2021 AHA/ACC chest pain guideline generally recommends repeat sampling at 1–3 hours for hs-cTn and 3–6 hours for conventional assays. The 2023 ESC ACS guideline recommends validated hs-cTn 0/1-hour or 0/2-hour algorithms. These are not interchangeable with the original ADAPT protocol.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.